Complementation of Plasmodium berghei TRAP knockout parasites using human dihydrofolate reductase gene as a selectable marker
- 1 March 2001
- journal article
- Published by Elsevier BV in Molecular and Biochemical Parasitology
- Vol. 113 (1), 151-156
- https://doi.org/10.1016/s0166-6851(01)00209-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Developmental arrest of the human malaria parasite Plasmodium falciparum within the mosquito midgut via CTRP gene disruptionMolecular Microbiology, 2000
- The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genomeMolecular and Biochemical Parasitology, 2000
- Targeted Disruption of the Plasmodium berghei Ctrp Gene Reveals Its Essential Role in Malaria Infection of the Vector MosquitoThe Journal of Experimental Medicine, 1999
- CTRP is essential for mosquito infection by malaria ookinetesThe EMBO Journal, 1999
- Stable transgene expression in Plasmodium falciparumMolecular and Biochemical Parasitology, 1997
- Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanilProceedings of the National Academy of Sciences, 1997
- TRAP Is Necessary for Gliding Motility and Infectivity of Plasmodium SporozoitesCell, 1997
- Circumsporozoite protein is required for development of malaria sporozoites in mosquitoesNature, 1997
- Stable Transfection of Malaria Parasite Blood StagesScience, 1995
- Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria.Proceedings of the National Academy of Sciences, 1993